Showing posts with label risk. Show all posts
Showing posts with label risk. Show all posts

Sunday, February 17, 2013

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.


Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.


Feb 2013


Source

C Olsen, Cancer Control Group, Queensland Institute of Medical Research, Brisbane, Australia.

Abstract

Whilst previous studies have reported that higher body-mass index (BMI) increases a woman's risk of developing ovarian cancer, associations for the different histological subtypes have not been well defined. As the prevalence of obesity has increased dramatically, and classification of ovarian histology has improved in the last decade, we sought to examine the association in a pooled analysis of recent studies participating in the Ovarian Cancer Association Consortium. We evaluated the association between BMI (recent, maximum, and in young adulthood) and ovarian cancer risk using original data from 15 case-control studies (13,548 cases, 17,913 controls). We combined study-specific adjusted odds ratios (ORs) using a random-effects model. We further examined the associations by histological subtype, menopausal status and post-menopausal hormone use. High BMI (all time-points) was associated with increased risk. This was most pronounced for borderline serous (recent BMI: pooled OR=1.24 per 5kg/m2; 95%CI 1.18-1.30), invasive endometrioid (1.17; 1.11-1.23) and invasive mucinous (1.19; 1.06-1.32) tumours. There was no association with serous invasive cancer overall (0.98; 0.94-1.02), but increased risks for low grade serous invasive tumours (1.13, 1.03-1.25) and in pre-menopausal women (1.11; 1.04-1.18). Among post-menopausal women, the associations did not differ between HRT users and non-users. Whilst obesity appears to increase risk of the less common histological subtypes of ovarian cancer, it does not increase risk of high grade invasive serous cancers, and reducing BMI is therefore unlikely to prevent the majority of ovarian cancer deaths. Other modifiable factors must be identified to control this disease.

Sunday, January 13, 2013

Breastfeeding babies can reduce a mother's risk of Ovarian cancer by two-thirds


Breastfeeding babies can reduce a mother's risk of Ovarian cancer by two-thirds



| 

Breastfeeding her baby can reduce a mother’s risk of ovarian cancer by nearly two-thirds, according to scientists.

And the longer she continues to do it, the greater the protection against the illness.

The research adds to evidence of the benefits of natural feeding as numerous studies  have already shown it cuts the chance of  breast cancer.

More than 6,000 patients a year in the UK are diagnosed with ovarian cancer, and the illness accounts for about 5 per cent of cancer deaths in women.

It is known as the ‘silent killer’ because symptoms for many sufferers, such as feeling bloated, are non-specific and the illness may not be diagnosed until it is fairly advanced.

For the latest study, Australian scientists studied 493 women diagnosed with ovarian cancer and compared them with 472 healthy volunteers of similar age.

Each was asked how many children they had and for how long they breastfed each one.

The results showed those who breastfed a child for at least 13 months were 63 per cent less likely to develop a tumour than those who did so for less than seven months.

The more children they had, the greater the effect, said the findings, published in the American Journal of Clinical Nutrition. Mothers who had three children and breastfed for a total of 31 months or more were found to cut their chances of ovarian tumours by 91 per cent. This was compared to those feeding naturally for a total of under ten months.

Breastfeeding is thought to help as it delays ovulation, when eggs are released and the ovaries are exposed to high levels of oestrogen-rich fluid.

Some researchers believe a higher number of ovulations raises the risk of mutant cells forming, which can trigger the disease.

But surveys have shown the UK has one of the lowest breastfeeding rates in Europe.

Nearly eight in ten mothers start when their baby is born but after six weeks, this is down to half.

After six months – the recommended time for exclusive breastfeeding – it is only 26 per cent.

The main risk factors for ovarian cancer include a family history of the disease, having already had breast cancer, starting periods at a young age and being overweight.

Dr Helga Groll, of Cancer Research UK, said the findings backed up earlier evidence on the benefits of breastfeeding.

But she warned that some mothers may not accurately remember for how long they had breastfed.

Gilda Witte, chief executive of Ovarian Cancer Action, added: ‘It is proven that breastfeeding can reduce the risk of ovarian cancer.

‘It does this because it reduces ovulation for the nursing mother.

‘The risk is further reduced by each child that a woman bears.’

MailOnline


Thursday, October 18, 2012

Ovarian cancer risk decreases with frequent aspirin use

Ovarian cancer risk decreases with frequent aspirin use


Decreasing a woman’s risk for ovarian cancer may be as simple as taking common pain relievers such as aspirin, suggests a new study from Denmark. Women taking aspirin at least twice a week for one month decreased their risk for ovarian cancer by 40 percent when compared to women not taking the medication as frequently.
While aspirin was indicated as a major factor for ovarian cancer risk, researchers also found other pain relievers evaluated in the study decreased the risk for serious cancers at a lesser rate. Drugs such as acetaminophen, ibuprofen and naproxen decrease serious cancer risk in women by approximately 28 percent.
The use of painkillers, however, must be taken with caution, as other studies indicate they generate addiction and lead to other serious health concerns.

Ovarian cancer and aspirin research

For the research, the Demark researchers evaluated 750 women with ovarian cancer as well as a control group of 1500 healthy women. The study participants were asked questions pertaining to overall health and what medications were taken regularly.
Contraceptives, which have also been noted to reduce the risk of ovarian cancer, were taken into consideration. At the end of the research period, experts surmised chronic inflammation may play a role in the development of ovarian cancer, and therefore the use of anti-inflammatories decreased a woman’s risk.

Dr. Noah Kauff, told My Health News Daily, director of ovarian cancer screening and prevention at Memorial Sloan-Kettering Cancer Center in New York City, told My Health News Daily, chronic inflammation from normal ovulation can result when the surface of the ovary sustains damage from releasing an egg. As the ovary attempts to repair its damaged surface, there is an increase in cell production and cell division—actions which raise the risk of abnormal cell growth known as cancer.
“We desperately need prevention strategies [for ovarian cancer],” he said, adding there are no good methods of detecting ovarian cancer, and therefore the disease often goes undiagnosed until it is in advanced stages.
Though considered uncommon, new cases of ovarian cancer affect approximately 20,000 women annually, with 90 percent of those women over the age of 40, according to the Centers for Disease Control (CDC).
Ovarian cancer is the fifth leading cause of cancer-related deaths, and it is the most deadly of all cancers in the female reproductive tract.
VOXXI

Sunday, September 16, 2012

Ovarian Cancer: The Fifth Leading Cause of Cancer Death


Ovarian Cancer: The Fifth Leading Cause of Cancer Death


Sunday September 16, 2012

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the ovaries, it is called ovarian cancer. Women have two ovaries that are located in the pelvis, one on each side of the uterus. The ovaries make female hormones and produce eggs.

Ovarian cancer causes more deaths than any other cancer of the female reproductive system. But when ovarian cancer is found in its early stages, treatment is most effective. Ovarian cancer often causes signs and symptoms, so it is important to pay attention to your body and know what is normal for you. Symptoms may be caused by something other than cancer, but the only way to know is to see your doctor, nurse, or other health care professional.

Who Gets Ovarian Cancer?


All women are at risk for ovarian cancer, but older women are more likely to get the disease than younger women. About 90% of women who get ovarian cancer are older than 40 years of age, with the greatest number of cases occurring in women aged 60 years or older.
Each year, about 20,000 women in the United States get ovarian cancer. Among women in the United States, ovarian cancer is the eighth most common cancer and the fifth leading cause of cancer death, after lung and bronchus, breast, colorectal, and pancreatic cancers. Ovarian cancer causes more deaths than any other cancer of the female reproductive system, but it accounts for only about 3% of all cancers in women. When ovarian cancer is found in its early stages, treatment is most effective.

Sunday, September 2, 2012

Annette Mattern: What Every Woman Should Know About Ovarian Cancer

Annette Mattern: What Every Woman Should Know About Ovarian Cancer


Annette Mattern: What Every Woman Should Know About Ovarian Cancer

“How do I know if I have ovarian cancer?” the question most asked by women about the disease that, for years, was called the silent killer. Ovarian cancer is the fifth leading cause of cancer-related death among U.S. women and yet, most women know very little about it.

What you should know:
1. Every woman is at risk.

2. One is 72 women will develop ovarian cancer; one in 95 women will die from it.

3. Increased risk factors:
• Personal history of breast cancer
• Family history of breast or ovarian cancer.
• BRCA1 or BRCA2 genes, responsible for 5-10% of ovarian cancers. Women of Ashkenazi Jewish descent are at higher risk of carrying these mutations.

4. There is no screening tool, not even the PAP, so it is critical that women recognize the symptoms as early as possible.
• Stage I recurrence rate is only 10%.
• Stage III or IV (about 75% of cases) recur 85-95% of the time. Their 5-year survival rate is only 46%.

5. 95% of women with ovarian cancer experience symptoms, 90% at early stage. Symptoms:
• Bloating
• Pelvic or abdominal pain
• Difficulty eating or feeling full too quickly
• Urinary urgency or frequency
Other symptoms: fatigue, indigestion, back pain, pain with intercourse, constipation and menstrual irregularities.

What you should do:
If you exhibit persistent symptoms for more than a few weeks and this is not normal for your body, see a gynecologist. Your exam may include a CA-125 blood test, pelvic exam, and a trans-vaginal ultrasound. The only conclusive way to determine if it is cancer is by performing a biopsy.

Help spread the word.
Most women with ovarian cancer were misdiagnosed for years while their cancer spread. An earlier diagnosis is a woman’s best hope for a good prognosis.

Bio notes:
Annette Mattern is a 21-year survivor of ovarian cancer and recently survived breast cancer. She is the founder and president of the Ovarian Cancer Alliance of Arizona and serves on the board of directors of the Ovarian Cancer National Alliance. Her book on survival, Outside The Lines of Love, Life, and Cancer, is available on www.amazon.com.

Links: www.ocaz.org
www.ovariancancer.org